Adenosin Life Medical 5 mg/ml

DRUG3 trials

Sponsors

Vastra Gotalandsregionen, Region Skane, Vaestra Goetalandsregionen

Conditions

Cardiovascular diseaseChronic coronary syndromeTakotsubo syndrome

Phase 3

Prognostic Performance of Quantitative Myocardial Perfusion Imaging Using H2[15O] Positron Emission Tomography in Coronary Artery Disease - The AQUA COR trial

Not yet recruitingCTIS2024-518706-41-01

Vaestra GoetalandsregionenCardiovascular disease

Target: 40000Updated: 2026-06-03

Phase 4

Optimized pharmacological treatment for broken heart (takotsubo) syndrome

RecruitingCTIS2022-501874-21-00

Vastra GotalandsregionenTakotsubo syndrome

Start: 2020-12-15Target: 1600Updated: 2025-05-16

HYPER-trial Hyperemic mYocardial Perfusion by adEnosine at diffeRent doses

RecruitingCTIS2023-505248-20-00

Region SkaneChronic coronary syndrome

Start: 2024-10-14Target: 180Updated: 2024-03-05